Living with Atopic Dermatitis poses numerous challenges, with relentless itching disrupting sleep, concentration and overall ...

The field of atopic dermatitis (AD) has been receiving great interest over the last few years with the approvals of both oral ...

Individuals who suffer from atopic dermatitis are three times more likely to develop anxiety, depression and sleep ...

Eczema affects millions of Americans, and any number of environmental and health factors can trigger flare-ups. What should ...

The U.S. Food and Drug Administration (FDA) announced the target action date of its review of the sNDA for VTAMA (tapinarof) cream, 1% has changed.

Eli Lilly's Ebglyss improves skin and itch symptoms in eczema patients, including Dupixent-treated cases, with positive Phase ...

The ADapt study assessed the efficacy and safety of EBGLYSS in individuals who had previously been treated with dupilumab.

New results show Eli Lilly Ebglyss (lebrikizumab-lbkz) improved skin (including hand and face) and itch among patients with ...

Given atopic dermatitis' negative impacts on quality of life among adolescents, including increased suicidality, "there remains a need for treatments available to this population," the authors ...

Eli Lilly (LLY) said a study of its drug Ebglyss showed it was able to improve skin and itch in patients with atopic ...

New results show Eli Lilly’s Ebglyss improved skin and itch among patients with moderate-to-severe atopic dermatitis who were previously treated with dupilumab. These results fr ...